These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24358767)

  • 1. [Novel targets for antibiotics discovery: riboswitches].
    Jia DF; Jia DF; Jia DF
    Yao Xue Xue Bao; 2013 Sep; 48(9):1361-8. PubMed ID: 24358767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riboswitches: discovery of drugs that target bacterial gene-regulatory RNAs.
    Deigan KE; Ferré-D'Amaré AR
    Acc Chem Res; 2011 Dec; 44(12):1329-38. PubMed ID: 21615107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand design for riboswitches, an emerging target class for novel antibiotics.
    Rekand IH; Brenk R
    Future Med Chem; 2017 Sep; 9(14):1649-1663. PubMed ID: 28925284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riboswitches: From living biosensors to novel targets of antibiotics.
    Mehdizadeh Aghdam E; Hejazi MS; Barzegar A
    Gene; 2016 Nov; 592(2):244-59. PubMed ID: 27432066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riboswitch-based antibacterial drug discovery using high-throughput screening methods.
    Penchovsky R; Stoilova CC
    Expert Opin Drug Discov; 2013 Jan; 8(1):65-82. PubMed ID: 23163232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds.
    Matzner D; Mayer G
    J Med Chem; 2015 Apr; 58(8):3275-86. PubMed ID: 25603286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial lysine analogs that target lysine riboswitches.
    Blount KF; Wang JX; Lim J; Sudarsan N; Breaker RR
    Nat Chem Biol; 2007 Jan; 3(1):44-9. PubMed ID: 17143270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and antimicrobial action of purine analogues that bind Guanine riboswitches.
    Kim JN; Blount KF; Puskarz I; Lim J; Link KH; Breaker RR
    ACS Chem Biol; 2009 Nov; 4(11):915-27. PubMed ID: 19739679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riboswitch distribution, structure, and function in bacteria.
    Pavlova N; Kaloudas D; Penchovsky R
    Gene; 2019 Aug; 708():38-48. PubMed ID: 31128223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promise of riboswitches as potential antibacterial drug targets.
    Lünse CE; Schüller A; Mayer G
    Int J Med Microbiol; 2014 Jan; 304(1):79-92. PubMed ID: 24140145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide bioinformatics analysis of FMN, SAM-I, glmS, TPP, lysine, purine, cobalamin, and SAH riboswitches for their applications as allosteric antibacterial drug targets in human pathogenic bacteria.
    Pavlova N; Penchovsky R
    Expert Opin Ther Targets; 2019 Jul; 23(7):631-643. PubMed ID: 31079546
    [No Abstract]   [Full Text] [Related]  

  • 12. Riboswitches as antibacterial drug targets.
    Blount KF; Breaker RR
    Nat Biotechnol; 2006 Dec; 24(12):1558-64. PubMed ID: 17160062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riboswitches as Drug Targets for Antibiotics.
    Panchal V; Brenk R
    Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33466288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system.
    Kirchner M; Schorpp K; Hadian K; Schneider S
    Sci Rep; 2017 Aug; 7(1):7732. PubMed ID: 28798404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways.
    Mulhbacher J; Brouillette E; Allard M; Fortier LC; Malouin F; Lafontaine DA
    PLoS Pathog; 2010 Apr; 6(4):e1000865. PubMed ID: 20421948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical Approaches to Bacterial Gene Regulation by Riboswitches.
    Perez-Gonzalez C; Grondin JP; Lafontaine DA; Carlos Penedo J
    Adv Exp Med Biol; 2016; 915():157-91. PubMed ID: 27193543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective small-molecule inhibition of an RNA structural element.
    Howe JA; Wang H; Fischmann TO; Balibar CJ; Xiao L; Galgoci AM; Malinverni JC; Mayhood T; Villafania A; Nahvi A; Murgolo N; Barbieri CM; Mann PA; Carr D; Xia E; Zuck P; Riley D; Painter RE; Walker SS; Sherborne B; de Jesus R; Pan W; Plotkin MA; Wu J; Rindgen D; Cummings J; Garlisi CG; Zhang R; Sheth PR; Gill CJ; Tang H; Roemer T
    Nature; 2015 Oct; 526(7575):672-7. PubMed ID: 26416753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Activity Relationship of Flavin Analogues That Target the Flavin Mononucleotide Riboswitch.
    Vicens Q; Mondragón E; Reyes FE; Coish P; Aristoff P; Berman J; Kaur H; Kells KW; Wickens P; Wilson J; Gadwood RC; Schostarez HJ; Suto RK; Blount KF; Batey RT
    ACS Chem Biol; 2018 Oct; 13(10):2908-2919. PubMed ID: 30107111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine analogs targeting the guanine riboswitch as potential antibiotics against Clostridioides difficile.
    Yan LH; Le Roux A; Boyapelly K; Lamontagne AM; Archambault MA; Picard-Jean F; Lalonde-Seguin D; St-Pierre E; Najmanovich RJ; Fortier LC; Lafontaine D; Marsault É
    Eur J Med Chem; 2018 Jan; 143():755-768. PubMed ID: 29220796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting.
    Wang H; Mann PA; Xiao L; Gill C; Galgoci AM; Howe JA; Villafania A; Barbieri CM; Malinverni JC; Sher X; Mayhood T; McCurry MD; Murgolo N; Flattery A; Mack M; Roemer T
    Cell Chem Biol; 2017 May; 24(5):576-588.e6. PubMed ID: 28434876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.